HSK42360

Other Medications

2 Clinical Trials

Description

HSK42360 is an investigational medication currently being studied in clinical trials for certain types of cancer. Specifically, trials are investigating its use in colorectal cancer patients whose tumors have a BRAF V600 mutation. These trials are in Phase 1, which means they are primarily focused on determining the safe dosage and identifying potential side effects. The trials are still recruiting participants. HSK42360 is being developed by Haisco Pharmaceutical Group Co., Ltd.

Mechanism of Action

HSK42360 is being studied in patients with solid tumors that have a specific genetic change called a BRAF V600 mutation. The exact way HSK42360 works (its specific molecular target or mechanism of action) is still being investigated in these early-phase clinical trials. Researchers are evaluating how the drug affects the body (pharmacokinetics) and its effects on the tumor (pharmacodynamics) as they determine the appropriate doses.

Side Effects

Because HSK42360 is an investigational drug in early-phase trials (Phase 1) The full range and frequency of potential side effects are still being evaluated. The primary goal of Phase 1 trials is to assess safety and determine the maximum tolerated dose. Information about specific side effects observed in these trials is not yet widely available But common side effects seen in cancer drug trials can include fatigue Nausea Diarrhea And changes in blood counts. More detailed information on side effects will become available as the trials progress.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT07561554 Phase 1
Recruiting
Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation
China
NCT06536400 Phase 1
Recruiting
Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation
China

Quick Info

CategoryOther Medications
Clinical Trials2
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.